Concepedia

Peter A. McSweeney

PA

120

Publications

22.8K

Citations

59

H-Index

1988

Active since

Affiliations

Fred Hutch Cancer Center(Current)

University of Washington

Colorado Blood Cancer Institute

Stanford University

University of California, Los Angeles

Peter A. McSweeney is an author at Fred Hutch Cancer Center specializing in medicine, hematology, and immunology.

Top concepts

Publications per year

1988–2024

120

Publications

120

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett et al. · New England Journal of Medicine · 2017 · 5.7K citations · Full text

Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial

Frederick L. Locke, Armin Ghobadi, Caron A. Jacobson et al. · The Lancet Oncology · 2018 · 2.2K citations

, , +9

KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma

Michael Wang, Javier Muñoz, André Goy et al. · New England Journal of Medicine · 2020 · 1.7K citations · Full text

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

Peter A. McSweeney, Dietger Niederwieser, Judith A. Shizuru et al. · Blood · 2001 · 1.4K citations

Ipilimumab for Patients with Relapse after Allogeneic Transplantation

Matthew S. Davids, Haesook T. Kim, Pavan Bachireddy et al. · New England Journal of Medicine · 2016 · 588 citations · Full text

Rows per page

1–5 of 120